| 1 | monoubiquitinated protein deubiquitination (GO:0035520) | 7.83436810 |
| 2 | outer ear morphogenesis (GO:0042473) | 7.73793797 |
| 3 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 6.67321383 |
| 4 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 6.67321383 |
| 5 | artery development (GO:0060840) | 6.25984438 |
| 6 | facial nerve structural organization (GO:0021612) | 5.47640368 |
| 7 | embryonic skeletal joint morphogenesis (GO:0060272) | 5.09714328 |
| 8 | endocardial cushion development (GO:0003197) | 4.89352089 |
| 9 | icosanoid secretion (GO:0032309) | 4.77042621 |
| 10 | arachidonic acid secretion (GO:0050482) | 4.77042621 |
| 11 | endosome to melanosome transport (GO:0035646) | 4.75509394 |
| 12 | endosome to pigment granule transport (GO:0043485) | 4.75509394 |
| 13 | kidney mesenchyme development (GO:0072074) | 4.72095836 |
| 14 | metanephric mesenchyme development (GO:0072075) | 4.44716288 |
| 15 | regulation of neurotransmitter uptake (GO:0051580) | 4.40400754 |
| 16 | cell migration involved in heart development (GO:0060973) | 4.29229162 |
| 17 | hyaluronan catabolic process (GO:0030214) | 4.28492231 |
| 18 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.28356943 |
| 19 | musculoskeletal movement (GO:0050881) | 4.27309594 |
| 20 | multicellular organismal movement (GO:0050879) | 4.27309594 |
| 21 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 4.23835781 |
| 22 | prepulse inhibition (GO:0060134) | 4.22660162 |
| 23 | pericardium development (GO:0060039) | 4.17040454 |
| 24 | polyamine biosynthetic process (GO:0006596) | 4.12215489 |
| 25 | negative regulation of sodium ion transport (GO:0010766) | 4.11237696 |
| 26 | protein K48-linked deubiquitination (GO:0071108) | 4.05313806 |
| 27 | behavioral response to cocaine (GO:0048148) | 4.00500729 |
| 28 | regulation of proton transport (GO:0010155) | 3.89868500 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 3.88920118 |
| 30 | G-protein coupled receptor internalization (GO:0002031) | 3.88736974 |
| 31 | synaptic transmission, dopaminergic (GO:0001963) | 3.87654032 |
| 32 | icosanoid transport (GO:0071715) | 3.84029566 |
| 33 | fatty acid derivative transport (GO:1901571) | 3.84029566 |
| 34 | base-excision repair, AP site formation (GO:0006285) | 3.80757974 |
| 35 | cranial nerve structural organization (GO:0021604) | 3.80684314 |
| 36 | negative regulation of membrane potential (GO:0045837) | 3.76976902 |
| 37 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.72269749 |
| 38 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.64199345 |
| 39 | platelet dense granule organization (GO:0060155) | 3.63731464 |
| 40 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.63544998 |
| 41 | cochlea morphogenesis (GO:0090103) | 3.54438287 |
| 42 | regulation of interleukin-8 secretion (GO:2000482) | 3.53787017 |
| 43 | eyelid development in camera-type eye (GO:0061029) | 3.52631165 |
| 44 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.48985232 |
| 45 | response to redox state (GO:0051775) | 3.48703604 |
| 46 | positive regulation of gastrulation (GO:2000543) | 3.46438033 |
| 47 | estrogen biosynthetic process (GO:0006703) | 3.39173949 |
| 48 | response to histamine (GO:0034776) | 3.36316418 |
| 49 | protein import into peroxisome matrix (GO:0016558) | 3.36222730 |
| 50 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.22266968 |
| 51 | smooth muscle tissue development (GO:0048745) | 3.22167034 |
| 52 | amine biosynthetic process (GO:0009309) | 3.21883964 |
| 53 | embryonic forelimb morphogenesis (GO:0035115) | 3.15632077 |
| 54 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.12659773 |
| 55 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.11056919 |
| 56 | regulation of cardioblast proliferation (GO:0003264) | 3.11056919 |
| 57 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.09383445 |
| 58 | fibroblast migration (GO:0010761) | 3.07771379 |
| 59 | negative regulation of protein autophosphorylation (GO:0031953) | 3.05611831 |
| 60 | middle ear morphogenesis (GO:0042474) | 3.03702729 |
| 61 | ovulation cycle (GO:0042698) | 3.03217515 |
| 62 | endocrine hormone secretion (GO:0060986) | 3.01366839 |
| 63 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.00662222 |
| 64 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.96095349 |
| 65 | fatty acid homeostasis (GO:0055089) | 2.94487673 |
| 66 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.93968705 |
| 67 | mesonephros development (GO:0001823) | 2.91797597 |
| 68 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.91107113 |
| 69 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.90807229 |
| 70 | reflex (GO:0060004) | 2.86406957 |
| 71 | head development (GO:0060322) | 2.85756012 |
| 72 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.82229550 |
| 73 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.79234731 |
| 74 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.76729648 |
| 75 | adipose tissue development (GO:0060612) | 2.74663247 |
| 76 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73260229 |
| 77 | regulation of mitochondrial translation (GO:0070129) | 2.71138217 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 2.69597137 |
| 79 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.69597137 |
| 80 | skin morphogenesis (GO:0043589) | 2.69446598 |
| 81 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.67862467 |
| 82 | regulation of endothelial cell differentiation (GO:0045601) | 2.65035056 |
| 83 | connective tissue development (GO:0061448) | 2.64904848 |
| 84 | forelimb morphogenesis (GO:0035136) | 2.63941205 |
| 85 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.62338262 |
| 86 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.60322994 |
| 87 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.58604061 |
| 88 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.56328169 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 2.55967925 |
| 90 | amine catabolic process (GO:0009310) | 2.55967925 |
| 91 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.53458416 |
| 92 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.53458416 |
| 93 | female pregnancy (GO:0007565) | 2.53147053 |
| 94 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.52598383 |
| 95 | ventricular septum development (GO:0003281) | 2.52306579 |
| 96 | parental behavior (GO:0060746) | 2.50447604 |
| 97 | membrane raft organization (GO:0031579) | 2.49993010 |
| 98 | early endosome to late endosome transport (GO:0045022) | 2.48933219 |
| 99 | pattern specification involved in kidney development (GO:0061004) | 2.48717306 |
| 100 | regulation of fibroblast migration (GO:0010762) | 2.48372419 |
PSG10P 
